InsiderTrades

Form 4 for MET MetLife

Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001099219-23-000077 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-02 2023-02-28+ MET McCallion John D. EVP, CFO F - Tax $71.68 -47.6K 155.3K -23% -$3.41M
DM 2023-03-02 2023-02-28 MET McCallion John D. EVP, CFO A - Grant — +92.8K 114.8K +422% —
D 2023-03-02 2023-02-28 MET McCallion John D. EVP, CFO A - Grant $0.00 +30.1K 30.1K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-01 F D 5,377 $71.27 149,957 D — —
2 Common Common Stock 2023-02-28 A A 82,782 — 197,590 D — — (F2) Shares acquired from the determination of the performance factor for and payout of 2020-2022 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
3 Common Common Stock 2023-02-28 A A 10,038 — 114,808 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
4 Common Common Stock 2023-02-28 F D 42,256 $71.73 155,334 D — —
5 Derivative Employee Stock Options (right to buy) 2023-02-28 A A 30,113 $0.00 30,113 D $71.73 · — to 2033-02-27 30,113 Common Stock (F5) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.